C
Clinomics Inc
KOSDAQ:352770
Clinomics Inc
KOSDAQ:352770
Price:
5 250
KRW
-20.63%
Market Cap:
₩13.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Clinomics Inc
KOSDAQ:352770
|
KR |
|
Buffalo Co Ltd
TSE:3352
|
JP |
|
Xingfa Aluminium Holdings Ltd
HKEX:98
|
CN |
|
E
|
eXoZymes Inc
NASDAQ:EXOZ
|
US |
|
A
|
Aubay SA
XBER:BAQ
|
FR |
|
C
|
Cresud SACIF y A
F:CD8
|
AR |
|
C
|
Corner Growth Acquisition Corp 2
NASDAQ:TRON
|
US |
Multiples-Based Value
The Multiples-Based Value of one Clinomics Inc stock under the Base Case scenario is hidden KRW. Compared to the current market price of 5 250 KRW, Clinomics Inc is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Clinomics Inc Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Clinomics Inc Competitors
Clinomics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
C
|
Clinomics Inc
KOSDAQ:352770
|
13.4B KRW | 2.4 | -0.3 | -0.9 | -0.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.1B USD | 6.2 | 90.8 | 15 | 20.8 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
362.4B USD | 111.6 | -1 741.9 | 16 180.3 | -1 827 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD | 5.2 | 24.7 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.1B USD | 5.9 | 20.5 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD | 9.5 | 28.7 | 21.6 | 22.6 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.2B USD | 5.7 | 18.2 | 13.7 | 15.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD | 3.2 | 34.9 | 11.5 | 14.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
